NCT01443026

The Effects of Lycopene on High Risk Prostatic Tissue

R01 CA90759: The Effects of Lycopene on High Risk Prostatic Tissue

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: University of Illinois at Chicago · Academic / Other
• Sex: Male
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this research study is to compare the effects of a lycopene supplement made from tomatoes to a placebo (a capsule with no active ingredients) in men who have abnormal cells in the prostate, but have not yet had cancer detected. This study will allow us to see if taking lycopene for six months leads to favorable changes in abnormal prostate tissue and in chemicals measured in the blood that go along with a higher risk of developing cancer.

Conditions

• Intraepithelial Prostatic Neoplasia
• Prostatic Neoplasms

Interventions

Type	Name	Description
DRUG	Lycopene 30mg	Lycopene 30 mg.
DRUG	Placebo	Placebo

Timeline

• Start date: 2006-02-01
• Primary completion: 2009-04-01
• Completion: 2009-04-01
• First posted: 2011-09-29
• Last updated: 2019-11-19
• Results posted: 2015-06-04

Locations

2 sites across 1 country: United States